Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1984973

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1984973

Deep Brain Stimulation In Parkinson's Disease Global Market Report 2026

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4490
PDF & Excel (Site License)
USD 6490
PDF & Excel (Enterprise License)
USD 8490

Add to Cart

Deep brain stimulation in Parkinson's disease is a medical intervention that involves implanting electrodes to deliver controlled electrical impulses to targeted regions of the brain. These impulses help alleviate motor symptoms such as tremors, rigidity, and slowed movements by modulating abnormal neural activity. It is usually suggested when medications are no longer effective in managing symptoms and seeks to enhance the overall quality of life for patients.

The key product types of deep brain stimulation in Parkinson's disease include implantable pulse generators, electrodes and leads, external programmers, and accessories and consumables. Implantable pulse generators deliver controlled electrical impulses to targeted brain regions to regulate abnormal neural activity. Technologies include conventional, closed-loop, and wireless stimulation systems, supported by services such as evaluation, implantation, device programming, monitoring, maintenance, rehabilitation support, tele-neurology, and training programs. Applications include tremor management, rigidity, bradykinesia, and dyskinesia, used by hospitals, ambulatory surgical centers, and neurology clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the deep brain stimulation market by increasing the cost of imported electrodes, implantable pulse generators, and specialized surgical tools, leading to higher treatment costs in affected regions. the impact is most pronounced in segments such as implantable devices and surgical implantation services, particularly in north america and europe where imports are significant. while tariffs may create cost pressures, they also encourage local manufacturing and innovation in device efficiency, potentially fostering regional supply chain resilience and long-term market growth.

The deep brain stimulation in parkinson's disease market research report is one of a series of new reports from The Business Research Company that provides deep brain stimulation in parkinson's disease market statistics, including deep brain stimulation in parkinson's disease industry global market size, regional shares, competitors with a deep brain stimulation in parkinson's disease market share, detailed deep brain stimulation in parkinson's disease market segments, market trends and opportunities, and any further data you may need to thrive in the deep brain stimulation in parkinson's disease industry. This deep brain stimulation in parkinson's disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The deep brain stimulation in parkinson's disease market size has grown strongly in recent years. It will grow from $3.27 billion in 2025 to $3.49 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing prevalence of Parkinson's disease, growing adoption of DBS devices, rising awareness of advanced neuromodulation therapies, expansion of neurosurgical infrastructure, and increasing healthcare spending.

The deep brain stimulation in parkinson's disease market size is expected to see strong growth in the next few years. It will grow to $4.49 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising demand for personalized neuromodulation therapies, growing investments in research and clinical trials, increasing access to tele-neurology services, expansion of reimbursement coverage, and rising adoption of MRI-compatible and rechargeable devices. Major trends in the forecast period include technological advancements in closed-loop and directional stimulation, innovations in rechargeable and long-life IPGs, developments in AI-assisted DBS programming, research and development in minimally invasive surgical techniques, and advancements in remote monitoring and telemedicine capabilities.

The rising number of Parkinson's disease patients is expected to propel the growth of the deep brain stimulation in Parkinson's disease market going forward. Parkinson's disease is a progressive neurological disorder that affects movement, causing symptoms such as tremors, stiffness, slowness of movement, and impaired balance due to the degeneration of dopamine-producing neurons in the brain. The rise in the number of Parkinson's disease patients is due to the aging population, as the risk of developing Parkinson's disease increases significantly with age. Deep brain stimulation helps manage Parkinson's disease by delivering targeted electrical impulses to specific brain regions, reducing motor symptoms, improving quality of life, and lowering dependence on long-term medication. For instance, in 2025, according to the Parkinson's Foundation, a US-based non-profit organization, an estimated 1.1 million people in the United States are living with Parkinson's disease, expected to rise to 1.2 million by 2030, with nearly 90,000 new diagnoses each year and more than 10 million people affected worldwide. Therefore, the rising number of Parkinson's disease patients is driving the growth of the deep brain stimulation in Parkinson's disease market.

The increasing healthcare expenditure is expected to drive the growth of the deep brain stimulation in Parkinson's disease sector in the coming years. Healthcare expenditure encompasses the total financial resources allocated to healthcare services, including medical treatments, hospital care, medications, and public health initiatives, by governments, businesses, and individuals. The rise in healthcare spending is largely due to the growing prevalence of chronic diseases, which necessitate long-term and expensive treatments. Higher healthcare expenditure supports deep brain stimulation in Parkinson's disease by funding advanced surgical procedures, medical equipment, and follow-up care. It enhances patient outcomes by expanding access to this effective therapy, which alleviates motor symptoms and improves quality of life. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure increased by 5.6% in nominal terms in 2023, reflecting a 0.9% rise compared to 2022. Consequently, the rising healthcare expenditure is fueling the growth of the deep brain stimulation in Parkinson's disease sector.

Leading companies in the deep brain stimulation for Parkinson's disease sector are concentrating on developing advanced technologies, such as miniaturizing rechargeable implantable pulse generators and incorporating remote programming platforms, to improve patient comfort and accessibility to care. Miniaturizing rechargeable implantable pulse generators involves designing these battery-powered neurostimulation devices in smaller, thinner forms, allowing for less invasive implantation while still delivering consistent therapeutic electrical pulses over extended periods. For example, in January 2024, Abbott Laboratories, a US-based multinational medical devices and healthcare company, introduced its Liberta RC DBS system. This platform is a miniaturized rechargeable deep brain stimulation system with remote programming functionality, aimed at treating individuals with movement disorders such as Parkinson's disease and essential tremor. The system also offers the longest recharge interval among FDA-approved DBS devices, requiring only 10 recharge sessions annually for most patients, and leverages the NeuroSphere Virtual Clinic to enable patients to connect with their doctors and receive treatment adjustments from home.

Major companies operating in the deep brain stimulation in parkinson's disease market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Mayo Foundation for Medical Education and Research, Cleveland Clinic, Renishaw plc, Neuralink Corp., NeuroPace Inc., PINS Medical Co. Ltd., Neurosoft Ltd., BrainsWay Ltd., Medscape, Inomed Medizintechnik GmbH, SceneRay Corporation Ltd., Neuroelectrics Barcelona S.L., Soterix Medical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, NeuroSigma Inc., BrainGate Company Inc.

North America was the largest region in the deep brain stimulation in parkinson's disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation in parkinson's disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the deep brain stimulation in parkinson's disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The deep brain stimulation in parkinson's disease market consists of revenues earned by entities by providing services such as neurosurgical implantation procedures, preoperative patient assessment services, device programming and calibration services, postoperative monitoring and follow-up care, and long-term therapy management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The deep brain stimulation in parkinson's disease market also includes sales of implantable neurostimulators, intracranial electrodes, extension leads, external programmers, and neurostimulation system accessories. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Deep Brain Stimulation In Parkinson's Disease Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses deep brain stimulation in parkinson's disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for deep brain stimulation in parkinson's disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deep brain stimulation in parkinson's disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Implantable Pulse Generators (IPGs); Electrodes And Leads; External Programmers; Accessories And Consumables
  • 2) By Technology: Conventional Deep Brain Stimulation (DBS) Systems; Closed Loop Deep Brain Stimulation (DBS) Systems; Wireless Deep Brain Stimulation (DBS) Systems
  • 3) By Service Type: Pre-Surgical Evaluation Services; Surgical Implantation Services; Device Programming Services; Patient Monitoring Services; Maintenance And Follow-Up Services; Rehabilitation Support Services; Tele-Neurology Support Services; Training And Education Services
  • 4) By Application: Tremor Management; Rigidity And Stiffness Management; Bradykinesia (Slow Movement) Management; Dyskinesia Management
  • 5) By End-Users: Hospitals; Ambulatory Surgical Centres; Neurology Clinics
  • Subsegments:
  • 1) By Implantable Pulse Generators (IPGs): Rechargeable Implantable Pulse Generators; Non-Rechargeable Implantable Pulse Generators; Directional Implantable Pulse Generators
  • 2) By Electrodes And Leads: Cylindrical Electrodes; Directional Electrodes; Stimulation Leads
  • 3) By External Programmers: Handheld External Programmers; Desktop External Programmers; Wireless External Programmers
  • 4) By Accessories And Consumables: Extension Cables; Battery Chargers; Surgical Tool Kits
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Mayo Foundation for Medical Education and Research; Cleveland Clinic; Renishaw plc; Neuralink Corp.; NeuroPace Inc.; PINS Medical Co. Ltd.; Neurosoft Ltd.; BrainsWay Ltd.; Medscape; Inomed Medizintechnik GmbH; SceneRay Corporation Ltd.; Neuroelectrics Barcelona S.L.; Soterix Medical Inc.; CorTec GmbH; Aleva Neurotherapeutics SA; NeuroSigma Inc.; BrainGate Company Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: ME6MDBSP01_G26Q1

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Deep Brain Stimulation In Parkinson's Disease Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Deep Brain Stimulation In Parkinson's Disease Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Deep Brain Stimulation In Parkinson's Disease Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Deep Brain Stimulation In Parkinson's Disease Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Minimally Invasive Neurosurgical Techniques
    • 4.2.2 Personalized Neuromodulation Therapy
    • 4.2.3 Wireless And Wearable Dbs Monitoring
    • 4.2.4 Remote Patient Monitoring And Telemedicine Integration
    • 4.2.5 Neurofeedback And Adaptive Stimulation Systems

5. Deep Brain Stimulation In Parkinson's Disease Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centres
  • 5.3 Neurology Clinics
  • 5.4 Rehabilitation Centres
  • 5.5 Research & Academic Institutions

6. Deep Brain Stimulation In Parkinson's Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Deep Brain Stimulation In Parkinson's Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Deep Brain Stimulation In Parkinson's Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Deep Brain Stimulation In Parkinson's Disease Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Deep Brain Stimulation In Parkinson's Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Deep Brain Stimulation In Parkinson's Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Deep Brain Stimulation In Parkinson's Disease Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Deep Brain Stimulation In Parkinson's Disease Market Segmentation

  • 9.1. Global Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Pulse Generators (IPGs), Electrodes And Leads, External Programmers, Accessories And Consumables
  • 9.2. Global Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Conventional Deep Brain Stimulation (DBS) Systems, Closed Loop Deep Brain Stimulation (DBS) Systems, Wireless Deep Brain Stimulation (DBS) Systems
  • 9.3. Global Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pre-Surgical Evaluation Services, Surgical Implantation Services, Device Programming Services, Patient Monitoring Services, Maintenance And Follow-Up Services, Rehabilitation Support Services, Tele-Neurology Support Services, Training And Education Services
  • 9.4. Global Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tremor Management, Rigidity And Stiffness Management, Bradykinesia (Slow Movement) Management, Dyskinesia Management
  • 9.5. Global Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centres, Neurology Clinics
  • 9.6. Global Deep Brain Stimulation In Parkinson's Disease Market, Sub-Segmentation Of Implantable Pulse Generators (IPGs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Rechargeable Implantable Pulse Generators, Non-Rechargeable Implantable Pulse Generators, Directional Implantable Pulse Generators
  • 9.7. Global Deep Brain Stimulation In Parkinson's Disease Market, Sub-Segmentation Of Electrodes And Leads, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cylindrical Electrodes, Directional Electrodes, Stimulation Leads
  • 9.8. Global Deep Brain Stimulation In Parkinson's Disease Market, Sub-Segmentation Of External Programmers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Handheld External Programmers, Desktop External Programmers, Wireless External Programmers
  • 9.9. Global Deep Brain Stimulation In Parkinson's Disease Market, Sub-Segmentation Of Accessories And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Extension Cables, Battery Chargers, Surgery Tool Kits

10. Deep Brain Stimulation In Parkinson's Disease Market Regional And Country Analysis

  • 10.1. Global Deep Brain Stimulation In Parkinson's Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Deep Brain Stimulation In Parkinson's Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Deep Brain Stimulation In Parkinson's Disease Market

  • 11.1. Asia-Pacific Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Deep Brain Stimulation In Parkinson's Disease Market

  • 12.1. China Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Deep Brain Stimulation In Parkinson's Disease Market

  • 13.1. India Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Deep Brain Stimulation In Parkinson's Disease Market

  • 14.1. Japan Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Deep Brain Stimulation In Parkinson's Disease Market

  • 15.1. Australia Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Deep Brain Stimulation In Parkinson's Disease Market

  • 16.1. Indonesia Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Deep Brain Stimulation In Parkinson's Disease Market

  • 17.1. South Korea Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Deep Brain Stimulation In Parkinson's Disease Market

  • 18.1. Taiwan Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Deep Brain Stimulation In Parkinson's Disease Market

  • 19.1. South East Asia Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Deep Brain Stimulation In Parkinson's Disease Market

  • 20.1. Western Europe Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Deep Brain Stimulation In Parkinson's Disease Market

  • 21.1. UK Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Deep Brain Stimulation In Parkinson's Disease Market

  • 22.1. Germany Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Deep Brain Stimulation In Parkinson's Disease Market

  • 23.1. France Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Deep Brain Stimulation In Parkinson's Disease Market

  • 24.1. Italy Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Deep Brain Stimulation In Parkinson's Disease Market

  • 25.1. Spain Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Deep Brain Stimulation In Parkinson's Disease Market

  • 26.1. Eastern Europe Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Deep Brain Stimulation In Parkinson's Disease Market

  • 27.1. Russia Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Deep Brain Stimulation In Parkinson's Disease Market

  • 28.1. North America Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Deep Brain Stimulation In Parkinson's Disease Market

  • 29.1. USA Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Deep Brain Stimulation In Parkinson's Disease Market

  • 30.1. Canada Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Deep Brain Stimulation In Parkinson's Disease Market

  • 31.1. South America Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Deep Brain Stimulation In Parkinson's Disease Market

  • 32.1. Brazil Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Deep Brain Stimulation In Parkinson's Disease Market

  • 33.1. Middle East Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Deep Brain Stimulation In Parkinson's Disease Market

  • 34.1. Africa Deep Brain Stimulation In Parkinson's Disease Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Deep Brain Stimulation In Parkinson's Disease Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Deep Brain Stimulation In Parkinson's Disease Market Regulatory and Investment Landscape

36. Deep Brain Stimulation In Parkinson's Disease Market Competitive Landscape And Company Profiles

  • 36.1. Deep Brain Stimulation In Parkinson's Disease Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Deep Brain Stimulation In Parkinson's Disease Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Deep Brain Stimulation In Parkinson's Disease Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Cleveland Clinic Overview, Products and Services, Strategy and Financial Analysis

37. Deep Brain Stimulation In Parkinson's Disease Market Other Major And Innovative Companies

  • Renishaw plc, Neuralink Corp., NeuroPace Inc., PINS Medical Co. Ltd., Neurosoft Ltd., BrainsWay Ltd., Medscape, Inomed Medizintechnik GmbH, SceneRay Corporation Ltd., Neuroelectrics Barcelona S.L., Soterix Medical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, NeuroSigma Inc., BrainGate Company Inc.

38. Global Deep Brain Stimulation In Parkinson's Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Deep Brain Stimulation In Parkinson's Disease Market

40. Deep Brain Stimulation In Parkinson's Disease Market High Potential Countries, Segments and Strategies

  • 40.1 Deep Brain Stimulation In Parkinson's Disease Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Deep Brain Stimulation In Parkinson's Disease Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Deep Brain Stimulation In Parkinson's Disease Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!